Simplex Trading, LLC Evelo Biosciences, Inc. Transaction History

Simplex Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	BUY	$0.17 - $1.57 $249 - $2,306	1,469 New	1,469 $0
Q2 2022 Aug 03, 2022	SELL	$1.46 - $3.55 $88,435 - $215,030	-60,572 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$2.66 - $6.63 $75,735 - $188,769	28,472 Added 88.7%	60,572 $205,000
Q4 2021 Feb 23, 2022	BUY	$6.07 - $12.0 $194,337 - $384,192	32,016 Added 38114.29%	32,100 $194,000
Q2 2021 Aug 12, 2021	SELL	$9.43 - $16.6 $1,235 - $2,174	-131 Reduced 60.93%	84 $1,000
Q1 2021 Apr 26, 2021	BUY	$9.71 - $18.6 $2,087 - $3,999	215 New	215 $2,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.